BACKGROUND: Although ovarian fine-needle aspiration (FNA) cytology is not commonly used as a primary modality of diagnosis for patients with ovarian lesions, many ovarian cysts are aspirated intraoperatively and occasionally for diagnostic purposes. Therefore, the ability to interpret these specimens remains critical. Previous studies have suggested a high specificity but low sensitivity as a limitation. The objective of the current study was to further explore the use and performance of ovarian cyst FNA for diagnosing malignancy at the study institution. METHODS: The electronic database was searched from 1998 through 2016 for ovarian cyst fluid cytology specimens; any concurrent or follow-up surgical pathology; and clinical information including patient age, radiology findings, and procedure type. Test performance was calculated using the surgical pathology diagnosis as the gold standard. RESULTS: A total of 459 ovarian cyst FNA specimens had the following diagnoses: 416 (90.6%) were diagnosed as benign, 32 (7.0%) as atypical, 4 (0.9%) as suspicious, and 7 (1.5%) as malignant. Overall, 300 specimens (65.4%) had a corresponding surgical pathology specimen. On follow-up, the rate of malignancy (including borderline neoplasms) for benign FNA was 10 of 264 specimens (3.8%), that for atypical FNA was 0 of 24 specimens (0%), that for suspicious FNA was 5 of 5 specimens (100%), and that for malignant FNA was 7 of 7 specimens (100%). Test sensitivity was 54.0% and test specificity was 100%. The positive predictive value was 1.00 and the negative predictive value was 0.97, with a disease (malignancy) prevalence of 7.33%. CONCLUSIONS: Ovarian cyst fluid cytology is highly specific and moderately sensitive for the detection of ovarian malignancies.
INTRODUCTION
Although standard practice guidelines recommend that the majority of ovarian cystic lesions, especially those with a solid component or elevated levels of serum tumor markers (ie, CA 125), be managed surgically, ultrasoundguided fine-needle aspiration (FNA) of ovarian cystic lesions occasionally is performed. Clinicians may perform an FNA in patients with tubo-ovarian abscesses or to confirm malignancy in patients who are unfit for surgery or who are receiving neoadjuvant therapy. 1 Furthermore, many FNA specimens are procured during a surgical procedure in which an ovarian cyst is removed or incidentally encountered. Regardless of the clinical circumstances under which ovarian cyst specimens are obtained, pathologists receiving such specimens are obligated to render a diagnosis. Therefore, it is important for cytopathologists to become familiar with the normal cellular components of ovarian cyst fluids as well as the common diagnoses, pitfalls, and performance characteristics of ovarian cyst FNA. Some known limitations of ovarian cyst FNA include low sensitivity for borderline tumors and false-positive results from follicular cysts. 2 Previous studies have yielded controversial results regarding the cytologichistologic correlation, with diagnostic sensitivity ranging from 0.25 3 to 0.95. 4, 5 The objective of the current study was to further assess the diagnostic performance of ovarian FNA undertaken at the Johns Hopkins Hospital in Baltimore, Maryland. At the study institution, many ovarian cyst aspirations are performed, often intraoperatively with a concurrent surgical excision specimen, which provides the opportunity to assess the cytologic-histologic correlation.
MATERIALS AND METHODS
After Institutional Review Board approval was obtained, the electronic archives at The Johns Hopkins Hospital were searched from 1998 through 2016 for all ovarian cyst fluid FNA specimens. Any concurrent or follow-up ovarian surgical pathology specimens also were identified. The surgical histologic diagnosis was considered the gold standard with which cyst fluid diagnoses were compared. When available, slides from selected cases of benign cysts, all borderline cases, and all malignant cases were reviewed by a cytopathologist. The electronic medical records were used to obtain clinical information including patient age and the size and radiologic characteristics (solid vs cystic or both) of the ovarian mass, and the method by which the cytology specimens were obtained (surgical or nonsurgical). The relationship between these variables and the presence of malignancy was explored. For the purposes of data analysis, benign and atypical cytology diagnoses were considered as negative diagnoses, whereas suspicious and malignant cytology diagnoses were considered as positive diagnoses. At the study institution, there are no set criteria for the adequacy of ovarian cyst fluid specimens containing only cyst fluid. For the purposes of the current study, if any volume of fluid was submitted, the specimen was considered satisfactory, and as a result none of the specimens was considered nondiagnostic. The use of ovarian FNA by year also was tabulated.
Statistical Analysis
Test performance statistics (ie, sensitivity, specificity, and positive and negative predictive values) were calculated using the surgical pathology specimen diagnosis as the gold standard. The 2-sided Student t test was used to compare continuous variables. P values <.05 were considered to be statistically significant.
RESULTS
During an 18-year period at the study institution, 459 ovarian cyst aspirations were performed among 446 patients. Of these aspirations, 300 (65.4%) had a concurrent or subsequent surgical pathology specimen. The mean age of all the patients was 39.5 years. The mean age of the patients for whom a surgical specimen was available was 41.6 years, whereas the average age of the patients without a surgical specimen was 35.5 years (P<.001). Of the 300 cases for which histologic specimens were available, the average age of those patients with a benign histology was 40.1 years, whereas that of patients with a malignancy or a borderline tumor was 48.2 years (P 5 .054).
The majority of cases were cystic ovarian lesions (412 cases; 89.8%), whereas 47 lesions (10.2%) were characterized as both solid and cystic. The average cyst size in all cases was 6.5 cm. The average cyst size in cases without a surgical specimen was 4.6 cm, whereas cases with concurrent or subsequent surgical specimens had an average size of 7.1 cm (P<.001). Among cases with concurrent or subsequent surgical specimens, the average cyst size was 6.7 cm in benign cases and 11.3 cm in malignant and borderline cases (P 5 .0003). The cyst size was unknown for 90 cases (19.6%). Table 1 summarizes the patient demographics and radiologic information. Surgical diagnoses by patient age are shown in Figure 1 .
In the current study, ovarian FNA specimens yielded the following diagnoses: 416 of 459 (90.6%) were diagnosed as benign, 32 (7.0%) as atypical, 4 (0.9%) as suspicious, and 7 (1.5%) as malignant. A total of 366 aspirations (79.7%) were performed during a concurrent laparoscopy or laparotomy. Of these, 75 (16.3%) FNA specimens were obtained intraoperatively without a corresponding surgical specimen, and all were benign. A total of 93 specimens (20.3%) were not obtained during a concurrent abdominal surgical procedure; 90 of these aspirates (96.8%) were ultrasound guided and 2 (2.2%) were performed during hysteroscopy, whereas 1 aspirate (1.1%) was computed tomography guided. Of the 300 cases with concurrent or subsequent surgical specimens, 291 aspirations (97.0%) were performed during surgery, 8 (2.7%) were aspirated under ultrasound guidance, and 1 (0.3%) was aspirated under hysteroscopy. Figure 2 shows the . The average number of FNAs performed during surgery was 19.3 (range, 7-31 aspirations) and the average number performed nonsurgically was 4.9 (range, 1-8 aspirations). The average cyst size for those aspirated intraoperatively was 7.2 cm, compared with 3.8 cm for cysts aspirated nonsurgically (P 5.024).
Of the 300 specimens with a concurrent or subsequent surgical resection specimen, 278 (92.7%) were benign, with 133 specimens (44.3%) diagnosed as nonneoplastic benign cysts and 145 specimens (48.3%) diagnosed as benign neoplasms. Of the benign cysts, 33 functional cysts were identified (24 follicular cysts and 9 corpus luteum cysts). A total of 15 malignancies (5.0%) and 7 borderline tumors (2.3%) were diagnosed from the surgical specimens. Table 2 summarizes the histologic diagnoses. Practically, it often is difficult to specify the cyst type even on histology; hence, "benign cyst, not otherwise specified" was the most common diagnosis. Aside from "benign cyst, not otherwise specified," the most common benign cysts were follicular cysts and endometriotic cysts (Fig. 3) , whereas the most common benign neoplastic cysts were serous cystadenoma, cystic teratoma (Fig. 4) , and mucinous cystadenoma (Fig. 5 ). The cytologic distinction between a benign cyst (ie, follicular cyst) and a benign neoplastic cyst (ie, serous cystadenoma) was possible when sufficient diagnostic material was aspirated (Fig. 6 ).
In the current study cohort of 300 patients with histologic follow-up, the specificity of ovarian cyst fluid FNA was 100%, with no false-positive results. Ovarian cyst fluid FNA was found to have an overall sensitivity of 54.6%, detecting 9 of 15 malignant tumors and 3 of 7 borderline tumors ( Table 3 ). The malignancies not detected by cytology included 2 of 2 yolk sac tumors, 2 of 6 high-grade serous carcinomas, 1 of 1 adult granulosa cell tumor, 1 of 4 metastatic carcinomas, and 4 of 7 borderline epithelial tumors (3 serous and 1 mucinous). The positive predictive value of ovarian cyst FNA was 1.00 and the negative predictive value was 0.97, with a disease prevalence (malignancy and borderline tumor) of 7.33%. If lesions evaluated by FNA only and with negative clinical followup to date also are considered to negative (159 lesions), this increased the negative predictive value to 0.98 and decreased the disease prevalence to 4.79%.
Seven of the 10 false-negative cases were sampled in conjunction with a surgical procedure, and the correct diagnosis was made on histology. Three cases were aspirated under ultrasound guidance. One of these cases included a concurrent positive core needle biopsy for metastatic carcinoma, whereas the other 2 cases were atypical proliferative serous tumors that were resected shortly after due to their large size and the patient's personal history of atypical proliferative serous tumors on the contralateral side. Therefore, no patients were harmed as a result of missed diagnoses. None of the patients without surgical follow-up had been diagnosed with a malignancy at the time of last follow-up. In addition, no cyst rupture or needle track seeding was identified in the patients found to have a malignancy.
Although for the purposes of the above analysis we classified benign and atypical diagnoses together, the current study population consisted of 32 cases diagnosed as atypical on cytology. Of these cases, 24 had a corresponding surgical pathology specimen, 7 of which were benign nonneoplastic cysts and 17 of which were benign neoplastic cysts (6 cystic teratomas, 6 mucinous cystadenomas, and 5 serous cystadenomas). None of the atypical Abbreviations: FNA, fine-needle aspiration; NOS, not otherwise specified.
Ovarian Cyst Fine Needle Aspiration/Zhou et al
Cancer Cytopathology
February 2018 diagnoses had borderline or malignant follow-up, meaning that if atypical diagnoses were considered negative, none would result in a false-negative diagnosis. We further explored the usefulness of FNA cytology in detecting benign ovarian neoplasms. If diagnoses in which a neoplasm was definitively diagnosed or could not be excluded were considered as positive diagnoses, then FNA detected only 27 of 145 benign neoplastic cysts. Of these 27 cases, 14 were cystic teratomas, 9 were mucinous cystadenomas, and 4 were serous cystadenomas.
DISCUSSION
In the current study, the majority of ovarian cysts aspirated were small and benign, and were found incidentally on imaging. The majority (79.7%) of ovarian cyst fluid specimens herein were obtained intraoperatively. FNA frequently was used when an incidental ovarian cyst was discovered at the time of surgery, which often was performed for another indication. Common examples are tubal ligation, Caesarian section, or hysterectomy for uterine fibroid tumors. In many of these cases (75 cases), the ovarian lesion was not biopsied intraoperatively for histology but only aspirated, most likely due to the small size and benign appearance. Conversely, a suspicious ovarian lesion may be aspirated at the time of removal as a diagnostic adjunct to histology and/or to facilitate removal. A minority of cases (19.6%) are evaluated by FNA performed under ultrasound guidance, through either a transvaginal or transabdominal approach.
The results of the current study found that ovarian cyst fluid FNA was highly specific (100%) but only moderately sensitive (54.6%) for ovarian malignancies. Despite this, the negative predictive value was very high (0.97) because of the very low pretest probability of the lesions aspirated. Cytology alone missed 6 of 15 malignancies and 4 of 7 borderline tumors, and these cases were characterized by hypocellularity or the presence of benign cells or cyst contents. Malignant cells were absent from the specimen, most likely due to sampling error, which is a common problem in FNA of cystic lesions from all areas of the body. Clinical history plays an important role because cyst contents such as mucin can lead to a suspicious diagnosis even if malignant cells are lacking, as in the case of metastatic pancreatic adenocarcinoma (Fig. 7 ). An example of ideal sampling demonstrates a hypercellular aspirate consisting of tumor cells (Fig. 8) , which allows for a straightforward diagnosis. When an FNA is diagnostic of malignancy, tumor grade and the presence of invasion still must be evaluated on histology. 6 In the current study, FNA was found to have a low sensitivity (12.6%) for definitively diagnosing benign ovarian neoplastic cysts as neoplasms. The majority of these cases (17 of 27 cases) were classified in the atypical category. Because benign nonneoplastic cysts typically are not excised, this may have led to an overrepresentation of neoplastic cysts in the current study cohort. With respect to benign neoplastic cysts, FNA was found to be best at detecting teratomas, in which the presence of squamous cells and/or keratinizing debris was a helpful clue (Fig. 4) . Strips of mucinous epithelium aided in the diagnosis of mucinous cystadenoma (Fig. 5) , whereas cuboidal epithelium with ciliary tufting suggested a serous cystadenoma (Fig. 6) .
The results of the current study are comparable to those of most other studies (Table 4) . [3] [4] [5] [7] [8] [9] [10] [11] [12] [13] [14] [15] The high (C) Serous cystadenomas were found to be slightly more cellular than follicular cysts. Although the lining cells shared morphological similarities with functional granulosa cells, the presence of cilia is a distinctive feature. Another distinctive yet rarely seen feature, psammomatous calcification, was not identified in any serous cystadenoma specimen. Original Article sensitivity seen in the studies by Pal et al 4 and Uguz et al 5 most likely are due to the high prevalence of malignancy in their study populations. It is interesting to note that for the purposes of the current study, none of the cases was considered as nondiagnostic because a volume of fluid was submitted for cytologic evaluation in all cases. The study institution does not have set criteria for the adequacy of ovarian cyst fluid. We reclassified 12 cases originally termed nondiagnostic as negative. Of these cases, 6 had surgical pathology follow-up, including 3 benign cysts and 3 benign neoplastic cysts. This indicates that the presence of cyst fluid may only be a reassuring finding, because no specimen containing cyst fluid only contributed to the false-negative diagnosis rate noted in the current study.
Other studies report nondiagnostic rates of 18% to 80%, 11 which likely reflect differences in diagnostic criteria. FNA of cystic lesions often yields hypocellular specimens or those comprised of blood only. This reflects sampling problems inherent to cystic lesions (ie, poor sampling of cyst-lining cells) and contributes to the low sensitivity noted.
Over time, we observed that the number of ovarian FNAs performed at the study institution peaked in 2007, and slowly decreased after that (Fig. 2 ). This coincides with guidelines from the American Congress of Obstetricians and Gynecologists released in 2008 that recommended against aspirating adnexal masses. 1 This primarily is due to a risk of cyst rupture and peritoneal seeding. In 2016, there was a small increase noted in nonsurgical ovarian FNA specimens. The reason for this is unknown, but indicates that the practice of ovarian cyst FNA is not diminishing, and may continue to change over time.
As expected, the data from the current study demonstrate that the ovarian malignancies in this cohort were more commonly identified in older patients (Table 1) (Fig.  1) . This suggests that FNA may be less advisable in older patients, who are more likely to have a malignancy and require surgical intervention. We also found a statistically significant difference in cyst size between benign and borderline/malignant lesions. Although size alone cannot be used to predict whether a cyst is benign, it can be used along with other radiological characteristics 16 and clinical factors such as age, estradiol level, and CA 125 level 17 when determining management. In addition, new tools are being developed to complement ovarian cyst FNA. Studies have found that ovarian cyst fluid contains many protein biomarkers that may be used for cancer detection. Benign and malignant cysts contain statistically different levels of protein C inhibitor, apolipoprotein C-I and C-III, serum amyloid 4, and transthyretin. 18, 19 Recently, the evaluation of DNA from ovarian cyst fluid using a multiplex Smears of thick colloidal mucin obscured the specimen and (A) only rare epithelial fragments could be identified. Due to the obscuring mucin, the cytomorphological features were difficult to evaluate for malignancy. In this case, given the patient's history of pancreatic adenocarcinoma, the findings of thick mucin aspirated from a recently developed ovarian cyst were highly suggestive of metastasis despite the absence of malignant cells.
polymerase chain reaction-based assay identified tumorspecific genetic mutations not found in benign tumors or nonneoplastic cases. 20 The mutated genes include TP53, BRAF, and KRAS, among others. 20 The approach used to triage ovarian cyst FNAs at the study institution, as shown in the data presented herein, is that younger patients with smaller lesions tend to be evaluated with FNA alone, without a surgical biopsy or surgical resection. Given the low prevalence of malignant lesions being aspirated, this appears to be effective. As other studies have proposed, the current study data also suggest that ovarian cyst FNA is likely to remain useful for young patients with a very low risk of malignancy who need to preserve their fertility. [21] [22] [23] FNA may possibly help to determine the etiology of infertility in patients undergoing in vitro fertilization, 24 and also could be performed safely in pregnant patients, in whom cysts mostly are benign. 25, 26 Provided clinicians are aware of the false-negative risk associated with ovarian cyst FNA and triage patients appropriately, the high negative predictive value (0.97) of ovarian cyst FNA can provide reassurance. Original Article
